Monograph Title Sort descending | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
LATANOPROST | ASSAY/Procedure | USPNF Online | Online | 29-Jul-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: Transfer 2.0 mg/mL of USP Latanoprost RS into a suitable volumetric flask, dissolve in dehydrated alcohol equivalent to 20% of the final volume, and dilute with chromatographic hexane to volume. Sample solution:… Read More |
LEVORPHANOL TARTRATE TABLETS | PERFORMANCE TESTS/Uniformity of Dosage Units 〈905〉 | USPNF Online | Online | 31-Mar-2023 | 1-Aug-2023 | NA | NA | In Sample solution: Change Nominally about 80 ug/mL of levorphanol tartrate in Diluent prepared as follows. to: Nominally about 80 µg/mL of levorphanol tartrate in Diluent prepared as follows. |
LIDOCAINE | ASSAY | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Procedure: Change Column: 3.9-mm × 30-cm; 4-µm packing L1 to: Column: 3.9-mm × 30-cm; 10-µm packing L1 |
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION | Assay for lidocaine hydrochloride | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine and Epinephrine Injection. to: Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine… Read More |
LIDOCAINE, RACEPINEPHRINE AND TETRACAINE HYDROCHLORIDES COMPOUNDED TOPICAL GEL | DEFINITION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | Change Prepare Lidocaine, Racepinephrine, and Tetracaine Hydrochlorides Compounded Topical Gel containing 40 mg/mL of lidocaine hydrochloride, 1 mg/mL of racepinephrine hydrochloride, and 10 mg/mL of tetracaine hydrochloride as follows (see Pharmaceutical… Read More |
LINEZOLID TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In Sensitivity solution: Change 0.5 ug/mL of USP Linezolid RS from Standard solution in Diluent to: 0.5 μg/mL of USP Linezolid RS from Standard solution in Diluent |
LINEZOLID TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Result = (rU/rS) × CS × V × (1/L) × 100 rU = peak response of linezolid from the Sample… Read More |
LYSINE ACETATE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
LYSINE HYDROCHLORIDE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
MAFENIDE ACETATE FOR TOPICAL SOLUTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In System suitability: Change Samples: System suitability solution, Standard solution A, and Standard solution B to: Samples: System suitability solution and Standard solution A AND … Read More |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
MECAMYLAMINE HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In USP Mecamylamine Related Compound A RS: Change N,1,7,7-Tetramethyl bicyclo [2.2.1]heptan-2-amine. C11H21N 167.29 to: N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride. C11… Read More |
MELENGESTROL ACETATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 396.52 to: 396.53 |
MELENGESTROL ACETATE | USP Reference standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Melengestrol Acetate Related Compound A RS: Change 16-Methylene-17α-hydroxy-4-pregnene-3,20-dione 17-acetate. to: 16-Methylene-3,20-dioxopregn-4-en-17-yl acetate. AND In USP Melengestrol Acetate Related Compound B RS: Change 17α-… Read More |
MELOXICAM ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Analysis: Change WU = weight of the Oral Suspension taken (mg) to: WU = weight of the Oral Suspension taken (g) |
MESO-ZEAXANTHIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-Zeaxanthin to: (3R,3′S)-Zeaxanthin |
MESO-ZEAXANTHIN | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
MESO-ZEAXANTHIN | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
MESO-ZEAXANTHIN PREPARATION | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
MESO-ZEAXANTHIN PREPARATION | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
MESO-ZEAXANTHIN PREPARATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
METAPROTERENOL SULFATE ORAL SOLUTION | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
METAPROTERENOL SULFATE TABLETS | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
METARAMINOL BITARTRATE | SPECIFIC TESTS/Content of Tartaric Acid | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = {[(VS−VB) × N × F]/2 × W} × 100 to: Result = {[(VS−VB) × N × F]/(2 × W)} × 100 |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer, Type C RS) to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | IDENTIFICATION/A. | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
METHOTREXATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Methotrexate System Suitability Mixture RS: Change C22H26N8O5 · HCl 518.95 to: C22H26N8O5 · xHCl |
METHSUXIMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Column efficiency: Change NTL 5800 theoretical plates to: NLT 5800 theoretical plates |
Methyl Acetate | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 74-20-9. to: CAS RN®: 79-20-9. |
METHYLBENZETHONIUM CHLORIDE | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/Analysis: Change Calculate the percentage of methylbenzethonium chloride (C28H44ClNO2 · H2O) in the portion of Methylbenzethonium Chloride taken: to: Calculate the percentage of… Read More |
METHYLENE BLUE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In footnote a in Table 2: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
METHYLENE BLUE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Azure B RS: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
METHYLNALTREXONE BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | Correct the chemical structure |
METHYLPHENIDATE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In USP Methylphenidate Related Compound A RS: Change α-Phenyl-2-piperidineacetic acid hydrochloride. to: (RS)-2-Phenyl-2-[(RS)-piperidin-2-yl]acetic acid hydrochloride. |
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In USP Methylphenidate Related Compound A RS: Change α-Phenyl-2-piperidineacetic acid hydrochloride. to: (RS)-2-Phenyl-2-[(RS)-piperidin-2-yl]acetic acid hydrochloride. |
METOLAZONE | IMPURITIES | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Organic Impurities/Chromatographic system/Column: Change 4.6-mm × 25-cm; 5-µm packing 1 to: 4.6-mm × 25-cm; 5-µm packing L1 |
METOLAZONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 16-Dec-2022 | 1-Jan-2023 | NA | NA | In Buffer: Change 1.38 g of monobasic potassium phosphate monohydrate in 900 mL of water. to: 1.38 g of monobasic sodium phosphate in 900 mL of water. |
MILBEMYCIN OXIME | CHEMICAL INFORMATION | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change 541.68 Milbemycin B, 5-O-demethyl-28-deoxy-25-methyl-6,28-epoxy-23-hydroxyimino-, [6R,23S,25S(E)]-; (2αE,4E,5′S,6R,6′S,8E,11R,13R,15S,17αR,… Read More |
MILK THISTLE CAPSULES | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
MILK THISTLE TABLETS | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
MIRTAZAPINE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 10-ketomirtazpine to: 10-ketomirtazapine AND In Table 1: Change 1-Ketomirtazpinec to: 1-Ketomirtazapinec |
MOMETASONE FUROATE TOPICAL SOLUTION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In test A: Change The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, both relative to the internal standard, as obtained in the Assay. to: The retention time of the major… Read More |
MUPIROCIN CALCIUM | CHEMICAL INFORMATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Change 1075.34 to: 1075.35 |
MUPIROCIN CALCIUM | IMPURITIES/Organic Impurities/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN CREAM | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN NASAL OINTMENT | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN OINTMENT | IMPURITIES/Organic Impurities/Table 2 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
NALOXONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Limit of Naloxone Related Compound D: Delete Sensitivity solution: 1.25 µg/mL of USP Naloxone Related Compound D RS in 0.1 N hydrochloric acid AND In System suitability/Samples: Delete Sensitivity solution,… Read More |